– Zhiyi Biotech anunció el primer sujeto dosificado en el ensayo clínico de fase 1 de EE. UU. de SK10, en desarrollo para el tratamiento de la diarrea inducida por quimioterapia GUANGZHOU, China, 25 de agosto, 2023 /PRNewswire/ — El 23 de agosto de 2023, Zhiyi Biotech anunció que los…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.